Summary

The global IVD Bioactive Raw Materials market size is predicted to grow from US$ 1486 million in 2025 to US$ 2074 million in 2031; it is expected to grow at a CAGR of 5.7% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
IVD (In Vitro Diagnostic) bioactive raw materials are biological substances used in the development and production of diagnostic tests that analyze samples like blood, urine, or tissues outside the human body. These materials include antigens, antibodies, enzymes, nucleic acids, and other proteins that enable accurate detection of diseases, infections, or health conditions. They are essential for the sensitivity, specificity, and reliability of IVD products such as rapid test kits, immunoassays, and molecular diagnostics. High-quality bioactive raw materials ensure consistent performance, making them critical components in both clinical diagnostics and research applications.
United States market for IVD Bioactive Raw Materials is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for IVD Bioactive Raw Materials is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for IVD Bioactive Raw Materials is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key IVD Bioactive Raw Materials players cover Merck, Roche, Medix Biochemica, Thermo Fisher, JSR Life Sciences (MBL), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “IVD Bioactive Raw Materials Industry Forecast” looks at past sales and reviews total world IVD Bioactive Raw Materials sales in 2024, providing a comprehensive analysis by region and market sector of projected IVD Bioactive Raw Materials sales for 2025 through 2031. With IVD Bioactive Raw Materials sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world IVD Bioactive Raw Materials industry.
This Insight Report provides a comprehensive analysis of the global IVD Bioactive Raw Materials landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on IVD Bioactive Raw Materials portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global IVD Bioactive Raw Materials market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for IVD Bioactive Raw Materials and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global IVD Bioactive Raw Materials.
This report presents a comprehensive overview, market shares, and growth opportunities of IVD Bioactive Raw Materials market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Monoclonal Antibodies
Polyclonal Antibodies
Recombinant Antibodies
Segmentation by Application:
Diabetes
Infectious Diseases
Oncology
Heart Disease
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Merck
Roche
Medix Biochemica
Thermo Fisher
JSR Life Sciences (MBL)
HyTest
BBI Solution
Meridian
Biosynth
Creative Diagnostics
Leinco Technologies
SERION Immunologics
MP Biomedicals
Autobio Diagnostics
Fapon Biotech
Sino Biological
Nanjing Vazyme Biotech
GenScript ProBio
OPERON
ABclonal
BioPorto
Glentham Life Sciences
ImmunoDiagnostics
Prahas Healthcare
Promega
Rockland Immunochemicals
Key Questions Addressed in this Report
What is the 10-year outlook for the global IVD Bioactive Raw Materials market?
What factors are driving IVD Bioactive Raw Materials market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do IVD Bioactive Raw Materials market opportunities vary by end market size?
How does IVD Bioactive Raw Materials break out by Type, by Application?

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global IVD Bioactive Raw Materials Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for IVD Bioactive Raw Materials by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for IVD Bioactive Raw Materials by Country/Region, 2020, 2024 & 2031
2.2 IVD Bioactive Raw Materials Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Polyclonal Antibodies
2.2.3 Recombinant Antibodies
2.3 IVD Bioactive Raw Materials Sales by Type
2.3.1 Global IVD Bioactive Raw Materials Sales Market Share by Type (2020-2025)
2.3.2 Global IVD Bioactive Raw Materials Revenue and Market Share by Type (2020-2025)
2.3.3 Global IVD Bioactive Raw Materials Sale Price by Type (2020-2025)
2.4 IVD Bioactive Raw Materials Segment by Application
2.4.1 Diabetes
2.4.2 Infectious Diseases
2.4.3 Oncology
2.4.4 Heart Disease
2.4.5 Others
2.5 IVD Bioactive Raw Materials Sales by Application
2.5.1 Global IVD Bioactive Raw Materials Sale Market Share by Application (2020-2025)
2.5.2 Global IVD Bioactive Raw Materials Revenue and Market Share by Application (2020-2025)
2.5.3 Global IVD Bioactive Raw Materials Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global IVD Bioactive Raw Materials Breakdown Data by Company
3.1.1 Global IVD Bioactive Raw Materials Annual Sales by Company (2020-2025)
3.1.2 Global IVD Bioactive Raw Materials Sales Market Share by Company (2020-2025)
3.2 Global IVD Bioactive Raw Materials Annual Revenue by Company (2020-2025)
3.2.1 Global IVD Bioactive Raw Materials Revenue by Company (2020-2025)
3.2.2 Global IVD Bioactive Raw Materials Revenue Market Share by Company (2020-2025)
3.3 Global IVD Bioactive Raw Materials Sale Price by Company
3.4 Key Manufacturers IVD Bioactive Raw Materials Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers IVD Bioactive Raw Materials Product Location Distribution
3.4.2 Players IVD Bioactive Raw Materials Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for IVD Bioactive Raw Materials by Geographic Region
4.1 World Historic IVD Bioactive Raw Materials Market Size by Geographic Region (2020-2025)
4.1.1 Global IVD Bioactive Raw Materials Annual Sales by Geographic Region (2020-2025)
4.1.2 Global IVD Bioactive Raw Materials Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic IVD Bioactive Raw Materials Market Size by Country/Region (2020-2025)
4.2.1 Global IVD Bioactive Raw Materials Annual Sales by Country/Region (2020-2025)
4.2.2 Global IVD Bioactive Raw Materials Annual Revenue by Country/Region (2020-2025)
4.3 Americas IVD Bioactive Raw Materials Sales Growth
4.4 APAC IVD Bioactive Raw Materials Sales Growth
4.5 Europe IVD Bioactive Raw Materials Sales Growth
4.6 Middle East & Africa IVD Bioactive Raw Materials Sales Growth
5 Americas
5.1 Americas IVD Bioactive Raw Materials Sales by Country
5.1.1 Americas IVD Bioactive Raw Materials Sales by Country (2020-2025)
5.1.2 Americas IVD Bioactive Raw Materials Revenue by Country (2020-2025)
5.2 Americas IVD Bioactive Raw Materials Sales by Type (2020-2025)
5.3 Americas IVD Bioactive Raw Materials Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC IVD Bioactive Raw Materials Sales by Region
6.1.1 APAC IVD Bioactive Raw Materials Sales by Region (2020-2025)
6.1.2 APAC IVD Bioactive Raw Materials Revenue by Region (2020-2025)
6.2 APAC IVD Bioactive Raw Materials Sales by Type (2020-2025)
6.3 APAC IVD Bioactive Raw Materials Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe IVD Bioactive Raw Materials by Country
7.1.1 Europe IVD Bioactive Raw Materials Sales by Country (2020-2025)
7.1.2 Europe IVD Bioactive Raw Materials Revenue by Country (2020-2025)
7.2 Europe IVD Bioactive Raw Materials Sales by Type (2020-2025)
7.3 Europe IVD Bioactive Raw Materials Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa IVD Bioactive Raw Materials by Country
8.1.1 Middle East & Africa IVD Bioactive Raw Materials Sales by Country (2020-2025)
8.1.2 Middle East & Africa IVD Bioactive Raw Materials Revenue by Country (2020-2025)
8.2 Middle East & Africa IVD Bioactive Raw Materials Sales by Type (2020-2025)
8.3 Middle East & Africa IVD Bioactive Raw Materials Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of IVD Bioactive Raw Materials
10.3 Manufacturing Process Analysis of IVD Bioactive Raw Materials
10.4 Industry Chain Structure of IVD Bioactive Raw Materials
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 IVD Bioactive Raw Materials Distributors
11.3 IVD Bioactive Raw Materials Customer
12 World Forecast Review for IVD Bioactive Raw Materials by Geographic Region
12.1 Global IVD Bioactive Raw Materials Market Size Forecast by Region
12.1.1 Global IVD Bioactive Raw Materials Forecast by Region (2026-2031)
12.1.2 Global IVD Bioactive Raw Materials Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global IVD Bioactive Raw Materials Forecast by Type (2026-2031)
12.7 Global IVD Bioactive Raw Materials Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck IVD Bioactive Raw Materials Product Portfolios and Specifications
13.1.3 Merck IVD Bioactive Raw Materials Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Roche
13.2.1 Roche Company Information
13.2.2 Roche IVD Bioactive Raw Materials Product Portfolios and Specifications
13.2.3 Roche IVD Bioactive Raw Materials Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Roche Main Business Overview
13.2.5 Roche Latest Developments
13.3 Medix Biochemica
13.3.1 Medix Biochemica Company Information
13.3.2 Medix Biochemica IVD Bioactive Raw Materials Product Portfolios and Specifications
13.3.3 Medix Biochemica IVD Bioactive Raw Materials Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Medix Biochemica Main Business Overview
13.3.5 Medix Biochemica Latest Developments
13.4 Thermo Fisher
13.4.1 Thermo Fisher Company Information
13.4.2 Thermo Fisher IVD Bioactive Raw Materials Product Portfolios and Specifications
13.4.3 Thermo Fisher IVD Bioactive Raw Materials Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Thermo Fisher Main Business Overview
13.4.5 Thermo Fisher Latest Developments
13.5 JSR Life Sciences (MBL)
13.5.1 JSR Life Sciences (MBL) Company Information
13.5.2 JSR Life Sciences (MBL) IVD Bioactive Raw Materials Product Portfolios and Specifications
13.5.3 JSR Life Sciences (MBL) IVD Bioactive Raw Materials Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 JSR Life Sciences (MBL) Main Business Overview
13.5.5 JSR Life Sciences (MBL) Latest Developments
13.6 HyTest
13.6.1 HyTest Company Information
13.6.2 HyTest IVD Bioactive Raw Materials Product Portfolios and Specifications
13.6.3 HyTest IVD Bioactive Raw Materials Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 HyTest Main Business Overview
13.6.5 HyTest Latest Developments
13.7 BBI Solution
13.7.1 BBI Solution Company Information
13.7.2 BBI Solution IVD Bioactive Raw Materials Product Portfolios and Specifications
13.7.3 BBI Solution IVD Bioactive Raw Materials Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 BBI Solution Main Business Overview
13.7.5 BBI Solution Latest Developments
13.8 Meridian
13.8.1 Meridian Company Information
13.8.2 Meridian IVD Bioactive Raw Materials Product Portfolios and Specifications
13.8.3 Meridian IVD Bioactive Raw Materials Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Meridian Main Business Overview
13.8.5 Meridian Latest Developments
13.9 Biosynth
13.9.1 Biosynth Company Information
13.9.2 Biosynth IVD Bioactive Raw Materials Product Portfolios and Specifications
13.9.3 Biosynth IVD Bioactive Raw Materials Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Biosynth Main Business Overview
13.9.5 Biosynth Latest Developments
13.10 Creative Diagnostics
13.10.1 Creative Diagnostics Company Information
13.10.2 Creative Diagnostics IVD Bioactive Raw Materials Product Portfolios and Specifications
13.10.3 Creative Diagnostics IVD Bioactive Raw Materials Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Creative Diagnostics Main Business Overview
13.10.5 Creative Diagnostics Latest Developments
13.11 Leinco Technologies
13.11.1 Leinco Technologies Company Information
13.11.2 Leinco Technologies IVD Bioactive Raw Materials Product Portfolios and Specifications
13.11.3 Leinco Technologies IVD Bioactive Raw Materials Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Leinco Technologies Main Business Overview
13.11.5 Leinco Technologies Latest Developments
13.12 SERION Immunologics
13.12.1 SERION Immunologics Company Information
13.12.2 SERION Immunologics IVD Bioactive Raw Materials Product Portfolios and Specifications
13.12.3 SERION Immunologics IVD Bioactive Raw Materials Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 SERION Immunologics Main Business Overview
13.12.5 SERION Immunologics Latest Developments
13.13 MP Biomedicals
13.13.1 MP Biomedicals Company Information
13.13.2 MP Biomedicals IVD Bioactive Raw Materials Product Portfolios and Specifications
13.13.3 MP Biomedicals IVD Bioactive Raw Materials Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 MP Biomedicals Main Business Overview
13.13.5 MP Biomedicals Latest Developments
13.14 Autobio Diagnostics
13.14.1 Autobio Diagnostics Company Information
13.14.2 Autobio Diagnostics IVD Bioactive Raw Materials Product Portfolios and Specifications
13.14.3 Autobio Diagnostics IVD Bioactive Raw Materials Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Autobio Diagnostics Main Business Overview
13.14.5 Autobio Diagnostics Latest Developments
13.15 Fapon Biotech
13.15.1 Fapon Biotech Company Information
13.15.2 Fapon Biotech IVD Bioactive Raw Materials Product Portfolios and Specifications
13.15.3 Fapon Biotech IVD Bioactive Raw Materials Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Fapon Biotech Main Business Overview
13.15.5 Fapon Biotech Latest Developments
13.16 Sino Biological
13.16.1 Sino Biological Company Information
13.16.2 Sino Biological IVD Bioactive Raw Materials Product Portfolios and Specifications
13.16.3 Sino Biological IVD Bioactive Raw Materials Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Sino Biological Main Business Overview
13.16.5 Sino Biological Latest Developments
13.17 Nanjing Vazyme Biotech
13.17.1 Nanjing Vazyme Biotech Company Information
13.17.2 Nanjing Vazyme Biotech IVD Bioactive Raw Materials Product Portfolios and Specifications
13.17.3 Nanjing Vazyme Biotech IVD Bioactive Raw Materials Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Nanjing Vazyme Biotech Main Business Overview
13.17.5 Nanjing Vazyme Biotech Latest Developments
13.18 GenScript ProBio
13.18.1 GenScript ProBio Company Information
13.18.2 GenScript ProBio IVD Bioactive Raw Materials Product Portfolios and Specifications
13.18.3 GenScript ProBio IVD Bioactive Raw Materials Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 GenScript ProBio Main Business Overview
13.18.5 GenScript ProBio Latest Developments
13.19 OPERON
13.19.1 OPERON Company Information
13.19.2 OPERON IVD Bioactive Raw Materials Product Portfolios and Specifications
13.19.3 OPERON IVD Bioactive Raw Materials Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 OPERON Main Business Overview
13.19.5 OPERON Latest Developments
13.20 ABclonal
13.20.1 ABclonal Company Information
13.20.2 ABclonal IVD Bioactive Raw Materials Product Portfolios and Specifications
13.20.3 ABclonal IVD Bioactive Raw Materials Sales, Revenue, Price and Gross Margin (2020-2025)
13.20.4 ABclonal Main Business Overview
13.20.5 ABclonal Latest Developments
13.21 BioPorto
13.21.1 BioPorto Company Information
13.21.2 BioPorto IVD Bioactive Raw Materials Product Portfolios and Specifications
13.21.3 BioPorto IVD Bioactive Raw Materials Sales, Revenue, Price and Gross Margin (2020-2025)
13.21.4 BioPorto Main Business Overview
13.21.5 BioPorto Latest Developments
13.22 Glentham Life Sciences
13.22.1 Glentham Life Sciences Company Information
13.22.2 Glentham Life Sciences IVD Bioactive Raw Materials Product Portfolios and Specifications
13.22.3 Glentham Life Sciences IVD Bioactive Raw Materials Sales, Revenue, Price and Gross Margin (2020-2025)
13.22.4 Glentham Life Sciences Main Business Overview
13.22.5 Glentham Life Sciences Latest Developments
13.23 ImmunoDiagnostics
13.23.1 ImmunoDiagnostics Company Information
13.23.2 ImmunoDiagnostics IVD Bioactive Raw Materials Product Portfolios and Specifications
13.23.3 ImmunoDiagnostics IVD Bioactive Raw Materials Sales, Revenue, Price and Gross Margin (2020-2025)
13.23.4 ImmunoDiagnostics Main Business Overview
13.23.5 ImmunoDiagnostics Latest Developments
13.24 Prahas Healthcare
13.24.1 Prahas Healthcare Company Information
13.24.2 Prahas Healthcare IVD Bioactive Raw Materials Product Portfolios and Specifications
13.24.3 Prahas Healthcare IVD Bioactive Raw Materials Sales, Revenue, Price and Gross Margin (2020-2025)
13.24.4 Prahas Healthcare Main Business Overview
13.24.5 Prahas Healthcare Latest Developments
13.25 Promega
13.25.1 Promega Company Information
13.25.2 Promega IVD Bioactive Raw Materials Product Portfolios and Specifications
13.25.3 Promega IVD Bioactive Raw Materials Sales, Revenue, Price and Gross Margin (2020-2025)
13.25.4 Promega Main Business Overview
13.25.5 Promega Latest Developments
13.26 Rockland Immunochemicals
13.26.1 Rockland Immunochemicals Company Information
13.26.2 Rockland Immunochemicals IVD Bioactive Raw Materials Product Portfolios and Specifications
13.26.3 Rockland Immunochemicals IVD Bioactive Raw Materials Sales, Revenue, Price and Gross Margin (2020-2025)
13.26.4 Rockland Immunochemicals Main Business Overview
13.26.5 Rockland Immunochemicals Latest Developments
14 Research Findings and Conclusion

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. IVD Bioactive Raw Materials Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. IVD Bioactive Raw Materials Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Monoclonal Antibodies
Table 4. Major Players of Polyclonal Antibodies
Table 5. Major Players of Recombinant Antibodies
Table 6. Global IVD Bioactive Raw Materials Sales by Type (2020-2025) & (Units)
Table 7. Global IVD Bioactive Raw Materials Sales Market Share by Type (2020-2025)
Table 8. Global IVD Bioactive Raw Materials Revenue by Type (2020-2025) & ($ million)
Table 9. Global IVD Bioactive Raw Materials Revenue Market Share by Type (2020-2025)
Table 10. Global IVD Bioactive Raw Materials Sale Price by Type (2020-2025) & (US$/Unit)
Table 11. Global IVD Bioactive Raw Materials Sale by Application (2020-2025) & (Units)
Table 12. Global IVD Bioactive Raw Materials Sale Market Share by Application (2020-2025)
Table 13. Global IVD Bioactive Raw Materials Revenue by Application (2020-2025) & ($ million)
Table 14. Global IVD Bioactive Raw Materials Revenue Market Share by Application (2020-2025)
Table 15. Global IVD Bioactive Raw Materials Sale Price by Application (2020-2025) & (US$/Unit)
Table 16. Global IVD Bioactive Raw Materials Sales by Company (2020-2025) & (Units)
Table 17. Global IVD Bioactive Raw Materials Sales Market Share by Company (2020-2025)
Table 18. Global IVD Bioactive Raw Materials Revenue by Company (2020-2025) & ($ millions)
Table 19. Global IVD Bioactive Raw Materials Revenue Market Share by Company (2020-2025)
Table 20. Global IVD Bioactive Raw Materials Sale Price by Company (2020-2025) & (US$/Unit)
Table 21. Key Manufacturers IVD Bioactive Raw Materials Producing Area Distribution and Sales Area
Table 22. Players IVD Bioactive Raw Materials Products Offered
Table 23. IVD Bioactive Raw Materials Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global IVD Bioactive Raw Materials Sales by Geographic Region (2020-2025) & (Units)
Table 27. Global IVD Bioactive Raw Materials Sales Market Share Geographic Region (2020-2025)
Table 28. Global IVD Bioactive Raw Materials Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global IVD Bioactive Raw Materials Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global IVD Bioactive Raw Materials Sales by Country/Region (2020-2025) & (Units)
Table 31. Global IVD Bioactive Raw Materials Sales Market Share by Country/Region (2020-2025)
Table 32. Global IVD Bioactive Raw Materials Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global IVD Bioactive Raw Materials Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas IVD Bioactive Raw Materials Sales by Country (2020-2025) & (Units)
Table 35. Americas IVD Bioactive Raw Materials Sales Market Share by Country (2020-2025)
Table 36. Americas IVD Bioactive Raw Materials Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas IVD Bioactive Raw Materials Sales by Type (2020-2025) & (Units)
Table 38. Americas IVD Bioactive Raw Materials Sales by Application (2020-2025) & (Units)
Table 39. APAC IVD Bioactive Raw Materials Sales by Region (2020-2025) & (Units)
Table 40. APAC IVD Bioactive Raw Materials Sales Market Share by Region (2020-2025)
Table 41. APAC IVD Bioactive Raw Materials Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC IVD Bioactive Raw Materials Sales by Type (2020-2025) & (Units)
Table 43. APAC IVD Bioactive Raw Materials Sales by Application (2020-2025) & (Units)
Table 44. Europe IVD Bioactive Raw Materials Sales by Country (2020-2025) & (Units)
Table 45. Europe IVD Bioactive Raw Materials Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe IVD Bioactive Raw Materials Sales by Type (2020-2025) & (Units)
Table 47. Europe IVD Bioactive Raw Materials Sales by Application (2020-2025) & (Units)
Table 48. Middle East & Africa IVD Bioactive Raw Materials Sales by Country (2020-2025) & (Units)
Table 49. Middle East & Africa IVD Bioactive Raw Materials Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa IVD Bioactive Raw Materials Sales by Type (2020-2025) & (Units)
Table 51. Middle East & Africa IVD Bioactive Raw Materials Sales by Application (2020-2025) & (Units)
Table 52. Key Market Drivers & Growth Opportunities of IVD Bioactive Raw Materials
Table 53. Key Market Challenges & Risks of IVD Bioactive Raw Materials
Table 54. Key Industry Trends of IVD Bioactive Raw Materials
Table 55. IVD Bioactive Raw Materials Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. IVD Bioactive Raw Materials Distributors List
Table 58. IVD Bioactive Raw Materials Customer List
Table 59. Global IVD Bioactive Raw Materials Sales Forecast by Region (2026-2031) & (Units)
Table 60. Global IVD Bioactive Raw Materials Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas IVD Bioactive Raw Materials Sales Forecast by Country (2026-2031) & (Units)
Table 62. Americas IVD Bioactive Raw Materials Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC IVD Bioactive Raw Materials Sales Forecast by Region (2026-2031) & (Units)
Table 64. APAC IVD Bioactive Raw Materials Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe IVD Bioactive Raw Materials Sales Forecast by Country (2026-2031) & (Units)
Table 66. Europe IVD Bioactive Raw Materials Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa IVD Bioactive Raw Materials Sales Forecast by Country (2026-2031) & (Units)
Table 68. Middle East & Africa IVD Bioactive Raw Materials Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global IVD Bioactive Raw Materials Sales Forecast by Type (2026-2031) & (Units)
Table 70. Global IVD Bioactive Raw Materials Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global IVD Bioactive Raw Materials Sales Forecast by Application (2026-2031) & (Units)
Table 72. Global IVD Bioactive Raw Materials Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Merck Basic Information, IVD Bioactive Raw Materials Manufacturing Base, Sales Area and Its Competitors
Table 74. Merck IVD Bioactive Raw Materials Product Portfolios and Specifications
Table 75. Merck IVD Bioactive Raw Materials Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 76. Merck Main Business
Table 77. Merck Latest Developments
Table 78. Roche Basic Information, IVD Bioactive Raw Materials Manufacturing Base, Sales Area and Its Competitors
Table 79. Roche IVD Bioactive Raw Materials Product Portfolios and Specifications
Table 80. Roche IVD Bioactive Raw Materials Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Roche Main Business
Table 82. Roche Latest Developments
Table 83. Medix Biochemica Basic Information, IVD Bioactive Raw Materials Manufacturing Base, Sales Area and Its Competitors
Table 84. Medix Biochemica IVD Bioactive Raw Materials Product Portfolios and Specifications
Table 85. Medix Biochemica IVD Bioactive Raw Materials Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 86. Medix Biochemica Main Business
Table 87. Medix Biochemica Latest Developments
Table 88. Thermo Fisher Basic Information, IVD Bioactive Raw Materials Manufacturing Base, Sales Area and Its Competitors
Table 89. Thermo Fisher IVD Bioactive Raw Materials Product Portfolios and Specifications
Table 90. Thermo Fisher IVD Bioactive Raw Materials Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 91. Thermo Fisher Main Business
Table 92. Thermo Fisher Latest Developments
Table 93. JSR Life Sciences (MBL) Basic Information, IVD Bioactive Raw Materials Manufacturing Base, Sales Area and Its Competitors
Table 94. JSR Life Sciences (MBL) IVD Bioactive Raw Materials Product Portfolios and Specifications
Table 95. JSR Life Sciences (MBL) IVD Bioactive Raw Materials Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 96. JSR Life Sciences (MBL) Main Business
Table 97. JSR Life Sciences (MBL) Latest Developments
Table 98. HyTest Basic Information, IVD Bioactive Raw Materials Manufacturing Base, Sales Area and Its Competitors
Table 99. HyTest IVD Bioactive Raw Materials Product Portfolios and Specifications
Table 100. HyTest IVD Bioactive Raw Materials Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 101. HyTest Main Business
Table 102. HyTest Latest Developments
Table 103. BBI Solution Basic Information, IVD Bioactive Raw Materials Manufacturing Base, Sales Area and Its Competitors
Table 104. BBI Solution IVD Bioactive Raw Materials Product Portfolios and Specifications
Table 105. BBI Solution IVD Bioactive Raw Materials Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 106. BBI Solution Main Business
Table 107. BBI Solution Latest Developments
Table 108. Meridian Basic Information, IVD Bioactive Raw Materials Manufacturing Base, Sales Area and Its Competitors
Table 109. Meridian IVD Bioactive Raw Materials Product Portfolios and Specifications
Table 110. Meridian IVD Bioactive Raw Materials Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 111. Meridian Main Business
Table 112. Meridian Latest Developments
Table 113. Biosynth Basic Information, IVD Bioactive Raw Materials Manufacturing Base, Sales Area and Its Competitors
Table 114. Biosynth IVD Bioactive Raw Materials Product Portfolios and Specifications
Table 115. Biosynth IVD Bioactive Raw Materials Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 116. Biosynth Main Business
Table 117. Biosynth Latest Developments
Table 118. Creative Diagnostics Basic Information, IVD Bioactive Raw Materials Manufacturing Base, Sales Area and Its Competitors
Table 119. Creative Diagnostics IVD Bioactive Raw Materials Product Portfolios and Specifications
Table 120. Creative Diagnostics IVD Bioactive Raw Materials Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 121. Creative Diagnostics Main Business
Table 122. Creative Diagnostics Latest Developments
Table 123. Leinco Technologies Basic Information, IVD Bioactive Raw Materials Manufacturing Base, Sales Area and Its Competitors
Table 124. Leinco Technologies IVD Bioactive Raw Materials Product Portfolios and Specifications
Table 125. Leinco Technologies IVD Bioactive Raw Materials Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 126. Leinco Technologies Main Business
Table 127. Leinco Technologies Latest Developments
Table 128. SERION Immunologics Basic Information, IVD Bioactive Raw Materials Manufacturing Base, Sales Area and Its Competitors
Table 129. SERION Immunologics IVD Bioactive Raw Materials Product Portfolios and Specifications
Table 130. SERION Immunologics IVD Bioactive Raw Materials Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 131. SERION Immunologics Main Business
Table 132. SERION Immunologics Latest Developments
Table 133. MP Biomedicals Basic Information, IVD Bioactive Raw Materials Manufacturing Base, Sales Area and Its Competitors
Table 134. MP Biomedicals IVD Bioactive Raw Materials Product Portfolios and Specifications
Table 135. MP Biomedicals IVD Bioactive Raw Materials Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 136. MP Biomedicals Main Business
Table 137. MP Biomedicals Latest Developments
Table 138. Autobio Diagnostics Basic Information, IVD Bioactive Raw Materials Manufacturing Base, Sales Area and Its Competitors
Table 139. Autobio Diagnostics IVD Bioactive Raw Materials Product Portfolios and Specifications
Table 140. Autobio Diagnostics IVD Bioactive Raw Materials Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 141. Autobio Diagnostics Main Business
Table 142. Autobio Diagnostics Latest Developments
Table 143. Fapon Biotech Basic Information, IVD Bioactive Raw Materials Manufacturing Base, Sales Area and Its Competitors
Table 144. Fapon Biotech IVD Bioactive Raw Materials Product Portfolios and Specifications
Table 145. Fapon Biotech IVD Bioactive Raw Materials Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 146. Fapon Biotech Main Business
Table 147. Fapon Biotech Latest Developments
Table 148. Sino Biological Basic Information, IVD Bioactive Raw Materials Manufacturing Base, Sales Area and Its Competitors
Table 149. Sino Biological IVD Bioactive Raw Materials Product Portfolios and Specifications
Table 150. Sino Biological IVD Bioactive Raw Materials Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 151. Sino Biological Main Business
Table 152. Sino Biological Latest Developments
Table 153. Nanjing Vazyme Biotech Basic Information, IVD Bioactive Raw Materials Manufacturing Base, Sales Area and Its Competitors
Table 154. Nanjing Vazyme Biotech IVD Bioactive Raw Materials Product Portfolios and Specifications
Table 155. Nanjing Vazyme Biotech IVD Bioactive Raw Materials Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 156. Nanjing Vazyme Biotech Main Business
Table 157. Nanjing Vazyme Biotech Latest Developments
Table 158. GenScript ProBio Basic Information, IVD Bioactive Raw Materials Manufacturing Base, Sales Area and Its Competitors
Table 159. GenScript ProBio IVD Bioactive Raw Materials Product Portfolios and Specifications
Table 160. GenScript ProBio IVD Bioactive Raw Materials Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 161. GenScript ProBio Main Business
Table 162. GenScript ProBio Latest Developments
Table 163. OPERON Basic Information, IVD Bioactive Raw Materials Manufacturing Base, Sales Area and Its Competitors
Table 164. OPERON IVD Bioactive Raw Materials Product Portfolios and Specifications
Table 165. OPERON IVD Bioactive Raw Materials Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 166. OPERON Main Business
Table 167. OPERON Latest Developments
Table 168. ABclonal Basic Information, IVD Bioactive Raw Materials Manufacturing Base, Sales Area and Its Competitors
Table 169. ABclonal IVD Bioactive Raw Materials Product Portfolios and Specifications
Table 170. ABclonal IVD Bioactive Raw Materials Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 171. ABclonal Main Business
Table 172. ABclonal Latest Developments
Table 173. BioPorto Basic Information, IVD Bioactive Raw Materials Manufacturing Base, Sales Area and Its Competitors
Table 174. BioPorto IVD Bioactive Raw Materials Product Portfolios and Specifications
Table 175. BioPorto IVD Bioactive Raw Materials Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 176. BioPorto Main Business
Table 177. BioPorto Latest Developments
Table 178. Glentham Life Sciences Basic Information, IVD Bioactive Raw Materials Manufacturing Base, Sales Area and Its Competitors
Table 179. Glentham Life Sciences IVD Bioactive Raw Materials Product Portfolios and Specifications
Table 180. Glentham Life Sciences IVD Bioactive Raw Materials Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 181. Glentham Life Sciences Main Business
Table 182. Glentham Life Sciences Latest Developments
Table 183. ImmunoDiagnostics Basic Information, IVD Bioactive Raw Materials Manufacturing Base, Sales Area and Its Competitors
Table 184. ImmunoDiagnostics IVD Bioactive Raw Materials Product Portfolios and Specifications
Table 185. ImmunoDiagnostics IVD Bioactive Raw Materials Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 186. ImmunoDiagnostics Main Business
Table 187. ImmunoDiagnostics Latest Developments
Table 188. Prahas Healthcare Basic Information, IVD Bioactive Raw Materials Manufacturing Base, Sales Area and Its Competitors
Table 189. Prahas Healthcare IVD Bioactive Raw Materials Product Portfolios and Specifications
Table 190. Prahas Healthcare IVD Bioactive Raw Materials Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 191. Prahas Healthcare Main Business
Table 192. Prahas Healthcare Latest Developments
Table 193. Promega Basic Information, IVD Bioactive Raw Materials Manufacturing Base, Sales Area and Its Competitors
Table 194. Promega IVD Bioactive Raw Materials Product Portfolios and Specifications
Table 195. Promega IVD Bioactive Raw Materials Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 196. Promega Main Business
Table 197. Promega Latest Developments
Table 198. Rockland Immunochemicals Basic Information, IVD Bioactive Raw Materials Manufacturing Base, Sales Area and Its Competitors
Table 199. Rockland Immunochemicals IVD Bioactive Raw Materials Product Portfolios and Specifications
Table 200. Rockland Immunochemicals IVD Bioactive Raw Materials Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 201. Rockland Immunochemicals Main Business
Table 202. Rockland Immunochemicals Latest Developments


List of Figures
Figure 1. Picture of IVD Bioactive Raw Materials
Figure 2. IVD Bioactive Raw Materials Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global IVD Bioactive Raw Materials Sales Growth Rate 2020-2031 (Units)
Figure 7. Global IVD Bioactive Raw Materials Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. IVD Bioactive Raw Materials Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. IVD Bioactive Raw Materials Sales Market Share by Country/Region (2024)
Figure 10. IVD Bioactive Raw Materials Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Monoclonal Antibodies
Figure 12. Product Picture of Polyclonal Antibodies
Figure 13. Product Picture of Recombinant Antibodies
Figure 14. Global IVD Bioactive Raw Materials Sales Market Share by Type in 2025
Figure 15. Global IVD Bioactive Raw Materials Revenue Market Share by Type (2020-2025)
Figure 16. IVD Bioactive Raw Materials Consumed in Diabetes
Figure 17. Global IVD Bioactive Raw Materials Market: Diabetes (2020-2025) & (Units)
Figure 18. IVD Bioactive Raw Materials Consumed in Infectious Diseases
Figure 19. Global IVD Bioactive Raw Materials Market: Infectious Diseases (2020-2025) & (Units)
Figure 20. IVD Bioactive Raw Materials Consumed in Oncology
Figure 21. Global IVD Bioactive Raw Materials Market: Oncology (2020-2025) & (Units)
Figure 22. IVD Bioactive Raw Materials Consumed in Heart Disease
Figure 23. Global IVD Bioactive Raw Materials Market: Heart Disease (2020-2025) & (Units)
Figure 24. IVD Bioactive Raw Materials Consumed in Others
Figure 25. Global IVD Bioactive Raw Materials Market: Others (2020-2025) & (Units)
Figure 26. Global IVD Bioactive Raw Materials Sale Market Share by Application (2024)
Figure 27. Global IVD Bioactive Raw Materials Revenue Market Share by Application in 2025
Figure 28. IVD Bioactive Raw Materials Sales by Company in 2025 (Units)
Figure 29. Global IVD Bioactive Raw Materials Sales Market Share by Company in 2025
Figure 30. IVD Bioactive Raw Materials Revenue by Company in 2025 ($ millions)
Figure 31. Global IVD Bioactive Raw Materials Revenue Market Share by Company in 2025
Figure 32. Global IVD Bioactive Raw Materials Sales Market Share by Geographic Region (2020-2025)
Figure 33. Global IVD Bioactive Raw Materials Revenue Market Share by Geographic Region in 2025
Figure 34. Americas IVD Bioactive Raw Materials Sales 2020-2025 (Units)
Figure 35. Americas IVD Bioactive Raw Materials Revenue 2020-2025 ($ millions)
Figure 36. APAC IVD Bioactive Raw Materials Sales 2020-2025 (Units)
Figure 37. APAC IVD Bioactive Raw Materials Revenue 2020-2025 ($ millions)
Figure 38. Europe IVD Bioactive Raw Materials Sales 2020-2025 (Units)
Figure 39. Europe IVD Bioactive Raw Materials Revenue 2020-2025 ($ millions)
Figure 40. Middle East & Africa IVD Bioactive Raw Materials Sales 2020-2025 (Units)
Figure 41. Middle East & Africa IVD Bioactive Raw Materials Revenue 2020-2025 ($ millions)
Figure 42. Americas IVD Bioactive Raw Materials Sales Market Share by Country in 2025
Figure 43. Americas IVD Bioactive Raw Materials Revenue Market Share by Country (2020-2025)
Figure 44. Americas IVD Bioactive Raw Materials Sales Market Share by Type (2020-2025)
Figure 45. Americas IVD Bioactive Raw Materials Sales Market Share by Application (2020-2025)
Figure 46. United States IVD Bioactive Raw Materials Revenue Growth 2020-2025 ($ millions)
Figure 47. Canada IVD Bioactive Raw Materials Revenue Growth 2020-2025 ($ millions)
Figure 48. Mexico IVD Bioactive Raw Materials Revenue Growth 2020-2025 ($ millions)
Figure 49. Brazil IVD Bioactive Raw Materials Revenue Growth 2020-2025 ($ millions)
Figure 50. APAC IVD Bioactive Raw Materials Sales Market Share by Region in 2025
Figure 51. APAC IVD Bioactive Raw Materials Revenue Market Share by Region (2020-2025)
Figure 52. APAC IVD Bioactive Raw Materials Sales Market Share by Type (2020-2025)
Figure 53. APAC IVD Bioactive Raw Materials Sales Market Share by Application (2020-2025)
Figure 54. China IVD Bioactive Raw Materials Revenue Growth 2020-2025 ($ millions)
Figure 55. Japan IVD Bioactive Raw Materials Revenue Growth 2020-2025 ($ millions)
Figure 56. South Korea IVD Bioactive Raw Materials Revenue Growth 2020-2025 ($ millions)
Figure 57. Southeast Asia IVD Bioactive Raw Materials Revenue Growth 2020-2025 ($ millions)
Figure 58. India IVD Bioactive Raw Materials Revenue Growth 2020-2025 ($ millions)
Figure 59. Australia IVD Bioactive Raw Materials Revenue Growth 2020-2025 ($ millions)
Figure 60. China Taiwan IVD Bioactive Raw Materials Revenue Growth 2020-2025 ($ millions)
Figure 61. Europe IVD Bioactive Raw Materials Sales Market Share by Country in 2025
Figure 62. Europe IVD Bioactive Raw Materials Revenue Market Share by Country (2020-2025)
Figure 63. Europe IVD Bioactive Raw Materials Sales Market Share by Type (2020-2025)
Figure 64. Europe IVD Bioactive Raw Materials Sales Market Share by Application (2020-2025)
Figure 65. Germany IVD Bioactive Raw Materials Revenue Growth 2020-2025 ($ millions)
Figure 66. France IVD Bioactive Raw Materials Revenue Growth 2020-2025 ($ millions)
Figure 67. UK IVD Bioactive Raw Materials Revenue Growth 2020-2025 ($ millions)
Figure 68. Italy IVD Bioactive Raw Materials Revenue Growth 2020-2025 ($ millions)
Figure 69. Russia IVD Bioactive Raw Materials Revenue Growth 2020-2025 ($ millions)
Figure 70. Middle East & Africa IVD Bioactive Raw Materials Sales Market Share by Country (2020-2025)
Figure 71. Middle East & Africa IVD Bioactive Raw Materials Sales Market Share by Type (2020-2025)
Figure 72. Middle East & Africa IVD Bioactive Raw Materials Sales Market Share by Application (2020-2025)
Figure 73. Egypt IVD Bioactive Raw Materials Revenue Growth 2020-2025 ($ millions)
Figure 74. South Africa IVD Bioactive Raw Materials Revenue Growth 2020-2025 ($ millions)
Figure 75. Israel IVD Bioactive Raw Materials Revenue Growth 2020-2025 ($ millions)
Figure 76. Turkey IVD Bioactive Raw Materials Revenue Growth 2020-2025 ($ millions)
Figure 77. GCC Countries IVD Bioactive Raw Materials Revenue Growth 2020-2025 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of IVD Bioactive Raw Materials in 2025
Figure 79. Manufacturing Process Analysis of IVD Bioactive Raw Materials
Figure 80. Industry Chain Structure of IVD Bioactive Raw Materials
Figure 81. Channels of Distribution
Figure 82. Global IVD Bioactive Raw Materials Sales Market Forecast by Region (2026-2031)
Figure 83. Global IVD Bioactive Raw Materials Revenue Market Share Forecast by Region (2026-2031)
Figure 84. Global IVD Bioactive Raw Materials Sales Market Share Forecast by Type (2026-2031)
Figure 85. Global IVD Bioactive Raw Materials Revenue Market Share Forecast by Type (2026-2031)
Figure 86. Global IVD Bioactive Raw Materials Sales Market Share Forecast by Application (2026-2031)
Figure 87. Global IVD Bioactive Raw Materials Revenue Market Share Forecast by Application (2026-2031)